Sinopharm Group

Sinopharm Group Co. Ltd. (operating under the China National Pharmaceutical Group) is the absolute largest, most dominant healthcare group in China, serving as the massive, state-backed backbone of the nation’s pharmaceutical distribution and manufacturing network. Headquartered in Beijing, Sinopharm’s sheer scale is globally unprecedented.

The company operates a colossal, highly integrated distribution network that comprehensively covers every single province, municipality, and autonomous region in China, delivering critical medications, vaccines, and medical devices to hundreds of thousands of hospitals, primary care clinics, and retail pharmacies. Sinopharm is fundamentally crucial to China’s national public health security, playing the leading role in the national strategic reserve of medicines and managing massive emergency supply deployments during crises, such as the COVID-19 pandemic. Furthermore, the company operates thousands of its own retail pharmacies across the country and dominates the complex cold-chain logistics market required for sensitive biologics and vaccines.

Beyond massive distribution capabilities, Sinopharm is a colossal manufacturer of pharmaceuticals and vaccines, producing heavily utilized products for both domestic and international markets. Through its deep integration with the state healthcare apparatus, immense logistical infrastructure, and massive financial resources, Sinopharm remains the undisputed titan of the rapidly growing Chinese healthcare sector, providing the indispensable foundational infrastructure for the nation’s entire medical supply chain.